Abstract
Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.
| Original language | English |
|---|---|
| Journal | National Cancer Institute. Journal (Print) |
| Volume | 103 |
| Issue number | 18 |
| Pages (from-to) | 1363-72 |
| Number of pages | 10 |
| ISSN | 0027-8874 |
| DOIs | |
| Publication status | Published - 2011 |
| Externally published | Yes |
Keywords
- Adult
- Age Factors
- Aged
- Analysis of Variance
- Antineoplastic Agents, Hormonal
- Breast Neoplasms
- Cohort Studies
- Confounding Factors (Epidemiology)
- Denmark
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Neoplasm Staging
- Predictive Value of Tests
- Prognosis
- Receptors, Estrogen
- Receptors, Progesterone
- Registries
- Risk Assessment
- Risk Factors
- Survival Analysis
- Tumor Markers, Biological
Fingerprint
Dive into the research topics of 'Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS